Drospirenone and ethinyl estradiol and Topiramate interaction

Drospirenone and ethinyl estradiol and Topiramate: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Drospirenone and ethinyl estradiol (Yaz) label · effective 2025-05-29

Moderate

Some drugs or herbal products that may decrease the effectiveness of hormonal contraceptives include phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampin, topiramate and products containing St.

Drug interactionsnames TopiramateView label on DailyMed
Minor

Counsel patients to use a back-up or alternative method of contraception when enzyme inducers are used with COCs.

Drug interactionsby drug classView label on DailyMed
Minor

Counsel women to use an alternative method of contraception or a back-up method when enzyme inducers are used with COCs, and to continue back-up contraception for 28 days after discontinuing the enzyme inducer to ensure contraceptive reliability.

Drug interactionsby drug classView label on DailyMed
Minor

In vitro , EE is a reversible inhibitor of CYP2C19, CYP1A1 and CYP1A2 as well as a mechanism-based inhibitor of CYP3A4/5, CYP2C8, and CYP2J2.

Drug interactionsby drug classView label on DailyMed
Minor

These results demonstrate that DRSP did not inhibit CYP2C19 and CYP3A4 in vivo .

Drug interactionsby drug classView label on DailyMed

From the Topiramate (Trokendi XR) label · effective 2026-03-20

Moderate

Contraceptives: Decreased contraceptive efficacy and increased breakthrough bleeding, especially at doses greater than 200 mg per day ( 7.5 )

Drug interactionsby drug classView label on DailyMed
Moderate

Contraceptives The possibility of decreased contraceptive efficacy and increased breakthrough bleeding may occur in patients taking contraceptive products with TROKENDI XR.

Drug interactionsby drug classView label on DailyMed
Moderate

Patients taking estrogen-containing or progestin-only contraceptives should be asked to report any change in their bleeding patterns.

Drug interactionsby drug classView label on DailyMed
Moderate

Contraceptive efficacy can be decreased even in the absence of breakthrough bleeding [see Clinical Pharmacology (12.3) ] .

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.